Skip to main content

Swiss National Bank

Bank

Position in KYMR — Kymera Therapeutics, Inc.

CIK 1582202 ZURICH, V8

Position in KYMR

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$10,331,767
+$2,460,862 QoQ
Shares Held
90,100
-4.7% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#75
of 275 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KYMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. KYMR ranks #31 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KYMR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,331,767 90,100
2026-03-31 $7,870,905 94,500
2025-12-31 $7,329,702 94,200
2025-09-30 $4,618,560 81,600
2025-06-30 $3,246,816 74,400
2025-03-31 $2,060,961 75,300
2024-12-31 $3,065,526 76,200
2024-09-30 $3,119,047 65,900
2024-06-30 $2,689,485 90,100
2024-03-31 $3,203,940 79,700
2023-12-31 $1,807,660 71,000
2023-09-30 $1,099,490 79,100
2023-06-30 $1,519,639 66,100
2023-03-31 $2,281,510 77,000
2022-12-31 $2,031,744 81,400
2022-09-30 $1,735,069 79,700
2022-06-30 $1,549,603 78,700
2022-03-31 $2,831,208 66,900
2021-12-31 $3,923,682 61,800
2021-09-30 $3,553,770 60,500
2021-06-30 $1,197,950 24,700
2021-03-31 $979,272 25,200
2020-12-31 $1,562,400 25,200